Search | Page 6 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. The Evaluation of iron overload through hepcidin level and its related factors in myelodysplastic syndromes.

    ... ferritin (SF), C-reactive protein (CRP), and erythropoietin were measured by routine standard laboratory assays. CD4+ ...

    Research Article last updated 05/14/2013 - 3:00pm.

  2. Revisiting use of growth factors in myelodysplastic syndromes

    ... colony-stimulating factor (G-CSF) and recombinant erythropoietin (EPO) has improved symptoms in MDS patients in addition to ...

    Research Article last updated 07/31/2012 - 12:57pm.

  3. Clinical use of erythropoietic stimulating agents in myelodysplastic syndromes

    ... symptoms. For more than 20 years, recombinant human erythropoietin has been available for clinical use, and it has been employed in an attempt to relieve MDS-related anemia. Erythropoietin-alpha, erythropoietin-beta, and more recently darbepoetin have ...

    Research Article last updated 10/31/2011 - 10:51am.

  4. Lenalidomide for treatment of myelodysplastic syndromes: current status and future directions.

    ... . In non-del(5q) patients, lenalidomide enhances erythropoietin receptor signaling. Future directions include use of ...

    Research Article last updated 10/11/2011 - 5:58pm.

  5. Azacitidine in lower-risk myelodysplastic syndromes.

    ... data for azacitidine combination therapy with erythropoietin , granulocyte colony-stimulating factor, and valproic ...

    Research Article last updated 10/11/2011 - 5:58pm.

  6. Durable long-term responses in patients with myelodysplastic syndromes treated with lenalidomide.

    ... despite previous treatment with recombinant erythropoietin . One patient began lenalidomide therapy because of ...

    Research Article last updated 10/11/2011 - 5:58pm.

  7. Weekly standard doses of rh-EPO are highly effective for the treatment of anemic patients with low-intermediate 1 risk myelodysplastic syndromes

    ... For more than 20 years erythropoietin (rHEPO) has largely been used to treat anemia in ...

    Research Article last updated 10/11/2011 - 5:58pm.

  8. Supportive Care

    ... therapy. Red cell growth factor is called erythropoietin or EPO for short. It is a hormone naturally produced in the liver. Man made forms of erythropoietin come in the brand names Epogen® and Procrit®. Darbapoietin, is ...

    Page last updated 08/29/2013 - 4:20pm.

  9. ASH 2012 - Reviewing MDS Progress from Research and Clinical Perspectives

    ... works for platelets in the way that growth factors like erythropoietin (Procrit®) or darbepoetin (Aranesp®) work for low red ... patient response for red blood cell growth factors such as erythropoietin, we now have a model to predict patient response ...

    Interview last updated 02/07/2013 - 1:28pm.

  10. Lower-Risk MDS: Diagnosis and Treatment Options

    ... abnormality, the next treatment to consider is erythropoietin (EPO). EPO is the hormone that stimulates red blood ... effect. If patients are producing suffi cient levels of erythropoietin on their own, there is a much lower chance of responding to ...

    Interview last updated 05/18/2012 - 1:28pm.